Construction and evaluation of an immunosuppression-mediated model of invasive Aspergillus niger lung disease in rats
Affiliation:

Hunan Prima Drug Research Center Co Ltd

Fund Project:

Hunan Province Enterprise Science and Technology Innovation and Entrepreneurship Team Support Program(2021)

  • Article
  • | |
  • Metrics
  • |
  • Reference [24]
  • | | | |
  • Comments
    Abstract:

    Abstract: Objective This study establishes a model of invasive Aspergillus niger lung disease in immunosuppressed rats to provide theoretical support for the pharmacodynamic evaluation of anti-invasive pulmonary aspergillosis drugs and mechanism studies. Methods Sixty SD rats were randomly divided into a normal control group, a cyclophosphamide control group, and a cyclophosphamide + fungal infection low, medium, and high dose group, with 12 animals in each group. General clinical observations were performed daily, and the serum levels of immunoglobulin G (IgG), immunoglobulin M (IgM) and serum galactomannan (GM) were detected by ELISA on the 3rd and 7th days of modeling, respectively, as well as the ratio of CD4+ and CD8+ cells and the content of white blood cells (WBCs) and neutrophils (Neu) in peripheral blood, and the load of Aspergillus niger in alveolar lavage were observed simultaneously and morphological changes of rat lung tissue. Results The rats in the cyclophosphamide control group and the cyclophosphamide+fungal infection group showed reduced voluntary activity and erect hair after modeling, and the rats in the cyclophosphamide+fungal infection group were accompanied by shortness of breath and audible wet rhonchi in the lungs; compared with the normal control group, the rats in the cyclophosphamide control group showed significant reductions in the levels of CD4+, WBC, Neu, IgG and IgM in the blood, and the proportion of CD8+ was significantly higher (P<0.05, P<0.01); compared with the cyclophosphamide control group, rats in the cyclophosphamide+fungal infection group showed significant decreases in blood levels of CD4+, WBC, Neu, IgG, IgM, and significant increases in levels of CD8+, GM, and the alveolar lavage load of Aspergillus niger (P<0.05, P<0.01); and the lung tissues of the cyclophosphamide+fungal infection rats in the low-, medium-, and high-dose groups showed mycelial distribution and destruction of alveolar epithelium, increase of bronchial epithelial cup cells in the alveoli, and infiltration of inflammatory cells, and the degree of lesions was positively correlated with the modeling dose. Conclusion In this study, we used Aspergillus niger combined with cyclophosphamide immunosuppressant to construct a model of invasive Aspergillus niger lung disease, and the duration of the disease was positively correlated with the concentration of the bacterial fluid and the modeling time, which confirms that the cellular immunity plays an important role in the pathogenesis of the disease, and at the same time the immunoglobulin can also affect the development of the disease process of invasive pulmonary aspergillosis, and it is speculated that the pathogenesis of invasive pulmonary aspergillosis may be related to the level of immunoglobulin in the humoral immunity.

    Reference
    [1] Anais H, Jesse R W, Toine M, et al. Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients [J]. Observational Study, 2022, 77(3): 283-291.
    [2] 周黎明.内参标化的肺泡灌洗液半乳甘露聚糖试验在侵袭性肺曲霉病诊断中的价值研究 [D]; 南昌大学, 2018.
    [3] Teclegiorgis G, Sondus A, Abdullah A, et al. APX001 is effective in the treatment of murine invasive pulmonary aspergillosis [J]. Antimicrob Agents Chemother. 2019, 63(2):e01713-18.
    [4] 栗方, 曹彬, 曲久鑫, 等.侵袭性肺曲霉菌病小鼠动物模型建立的实验研究[J]. 中华临床医师杂志(电子版), 2015, 9(08): 1403-1407.
    [5] Song L, Zhao Y, Wang G, et al. Investigation of predictors for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome[J]. Sci Rep. 2023,13(1):1538.
    [6] Espie D, Donnadieu E, Hünniger K, et al. CAR T cells targeting aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models[J]. Sci Transl Med. 2022 ,14(664):eabh1209.
    [7] Denning D W. Therapeutic outcome in invasive aspergillosis [J]. Clin Infect Dis, 1996, 23(3): 608-615.
    [8] Tong X, Liu T, Jiang K, et al. Clinical characteristics and prognostic risk factors of patients with proven invasive pulmonary aspergillosis: A single-institution retrospective study [J]. Front Med (Lausanne), 2021, 8: 756237.
    [9] Atchade E, Jean-baptiste S, Hou ze S, et al. Fatal invasive aspergillosis caused by Aspergillus niger after bilateral lung transplantation [J]. Med Mycol Case Rep, 2017, 17: 4-7.
    [10] 林亚纳,张小菲,洪亚妮等.不同免疫状态侵袭性肺曲霉菌病患者实验室指标分析[J].中国免疫学杂志,2023,39(10):2211-2216.
    [11] 刘继红,陈黛诗,李展等.流感病毒及新型冠状病毒相关侵袭性肺曲霉病的诊治进展[J/OL].解放军医学院学报:1-7[2023-10-24].
    [12] 金文芳.侵袭性肺曲霉病的临床特点及其危险因素分析 [D]; 安徽医科大学, 2019.
    [13] 赵澄,张香港,王小奇等.免疫抑制剂环磷酰胺对流感病毒性肺炎小鼠模型“肺外传变”的影响[J/OL].中国免疫学杂志:1-17[2023-10-24].
    [14] 康慧琳,樊卫平,雷波等.不同剂量环磷酰胺对小鼠免疫功能的影响[J].免疫学杂志,2018,34(04):308-312.
    [15] Feng C, Zhang M, Zhang S, et al. Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice[J]. BMC Pulm Med. 2021,19;21(1):31.
    [16] 马欣雨,于世寰.侵袭性肺曲霉菌病检测方法进展[J].临床与病理杂志,2020,40(06):1584-1589.
    [17] Vandewoude KH, Blot SI, Depuydt P, et al. Clinical relevance of aspergillus isolation from respiratory tract samples in critically ill patients[J]. Crit Care. 2006,10(1):R31.
    [18] 彭冬冬,陈相池,夏伟等.大鼠混合细菌感染性肺炎模型的建立与评价[J].中国实验动物学报,2021,29(06):800-807.
    [19] Lawler C, Stevenson PG. A CD4+ T cell-NK cell Axis of gammaherpesvirus control[J]. J Virol. 2020,17;94(3).
    [20] Zander R, Schauder D, Xin G, et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer. immunity[J]. 2019, 51(6):1028-1042.
    [21] 刘欢,王锁英,李红.利可君对流感病毒感染伴中性粒细胞减少患儿的疗效评估[J].江苏大学学报(医学版),2023,33(04):333-337.
    [22] 王润超,万喆,李若瑜.21例侵袭性肺曲霉病患者Th以及Treg细胞的检测[J].中国真菌学杂志,2014,9(05):287-292.
    [23] 黄晓茹,林珊,张忠龙等.鼻病毒引起儿童支气管肺炎41例免疫功能变化分析[J].福建医药杂志,2023,45(02):67-69.
    [24] 江娟,李静,夏可等.反复肺炎患儿肠道菌群与免疫功能指标变化及相关性研究[J].陕西医学杂志,2023,52(09):1200-1203.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:218
  • PDF: 0
  • HTML: 0
  • Cited by: 0
History
  • Received:October 25,2023
  • Revised:March 26,2024
  • Adopted:June 17,2024
Article QR Code